ArticleMedicine2026
Association between life's essential 8 and epilepsy: A cross-sectional study (NHANES 2013-2018).
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epilepsy, a prevalent chronic neurological disorder, has significant neurobiological, cognitive, psychological, and social implications. The American Heart Association (AHA) introduced Life's Essential 8 as a key metric for assessing cardiovascular health. This study aims to investigate the association between Life's Essential 8 and epilepsy prevalence, offering population-level evidence on the potential clinical and public health relevance of cardiovascular health in individuals with epilepsy. Data were obtained from the National Health and Nutrition Examination Survey (NHANES) 2013 to 2018. A cross-sectional design was used, and logistic regression models, subgroup analyses were utilized to assess the association between LE8 and the prevalence of epilepsy. Restricted cubic splines were utilized to examine the nonlinear correlations. A total of 9408 participants were included in the study. After adjusting for potential confounding factors, LE8 showed a significant inverse association with the odds of epilepsy (odds ratio = 0.98, 95% confidence interval [CI]: 0.96-0.99). Restricted cubic spline analysis revealed a linear relationship between LE8 and the odds of epilepsy (P for nonlinearity = .658). Further analysis indicated that the diet score was significantly inversely associated with the odds of epilepsy (odds ratio = 0.99, 95% CI: 0.98-0.99). Subgroup analysis showed no significant interaction between confounding factors and LE8 on the odds of epilepsy (all interaction P values > .05). Higher LE8 scores were independently associated with lower odds of epilepsy. Despite the modest effect size, these findings suggest potential clinical and public health implications, highlighting the importance of promoting cardiovascular health behaviors, particularly dietary improvements, in relation to epilepsy prevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.